Stanford, CANCT06538649Now EnrollingIRB Ready

Crohn's Ileocolitis Clinical Trial in Stanford, CA

Access cutting-edge crohn's ileocolitis treatment through this early phase 1 clinical trial at a research site in Stanford. Study-provided care at no cost to qualified participants.

Sponsored by Stanford University

Quick Self-Assessment

See if you qualify for this Stanford location

Preparing your pre-screening questions…

Expert Care in Stanford

Access crohn's ileocolitis specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related crohn's ileocolitis treatment provided free

Apply for This Stanford Location

Check if you qualify for this crohn's ileocolitis clinical trial in Stanford, CA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Stanford

    Convenient for CA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Stanford site if eligible
  4. 4Begin participation

About This Crohn's Ileocolitis Study in Stanford

The goal of this clinical trial is to learn if statins work to prevent strictures in adults with Crohn's disease. The main question it aims to answer is: * Can statins reduce the formation of strictures in participants with stricturing Crohn's disease? Researchers will compare statins to a placebo (a look-a-like substance that contains no drug) to see if statins work to prevent strictures from forming. Participants will: * Take statins or a placebo every day for 6-12 months * Visit the clinic for lab tests twice after starting either statins or placebo * Complete questionnaires about symptoms and medications * Respond to monthly check-ins (via phone call) during participation

Sponsor: Stanford University

Who Can Participate

Inclusion Criteria

Established diagnosis of stricturing Crohn's disease
Scheduled for surgical resection of terminal ileum strictures at either
Stanford University, or
Dr. Phillip Fleshner's colorectal surgery practice in Los Angeles

Exclusion Criteria

Pregnant, nursing, or planning to become pregnant in the next 6-12 months
Severe renal dysfunction (stage 5 chronic kidney disease (CKD), end-stage renal disease (ESRD))
Known clinical allergy or prior adverse reaction to statin therapy (e.g., rhabdomyolysis)
Current use of cyclosporine
Current use of statin therapy prior to study initiation
Clinical diagnosis of active liver disease (beyond metabolic dysfunction-associated steatotic liver disease (MASLD)) with unexplained persistent elevations in hepatic transaminase levels
Current use of any of the following medications, without explicit clearance from a treating physician to enroll in the study:
Antifungals (e.g., ketoconazole, itraconazole, voriconazole)
Fibrate drugs
Macrolide antibiotics (e.g., erythromycin, clarithromycin)
Protease inhibitors (e.g., ritonavir, lopinavir)
Calcium channel blockers (e.g., verapamil, diltiazem)

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Stanford?

Yes, this clinical trial (NCT06538649) has an active research site in Stanford, CA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Crohn's Ileocolitis Treatment Options in Stanford, CA

If you're searching for crohn's ileocolitis treatment options in Stanford, CA, this clinical trial (NCT06538649) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Stanford research site is actively enrolling participants for this early phase 1 clinical trial. You'll receive care from experienced crohn's ileocolitis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all crohn's ileocolitis clinical trials near you to find additional studies recruiting in your area.

More Crohns Disease Trials in Stanford, CA

See all crohns disease clinical trials recruiting in Stanford — not just this study.

Browse Crohns Disease Trials in Stanford →

Ready to Join in Stanford?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Stanford, CA